{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:50:09Z","timestamp":1773273009764,"version":"3.50.1"},"reference-count":138,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T00:00:00Z","timestamp":1389139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0085346","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T22:13:01Z","timestamp":1389219181000},"page":"e85346","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":57,"title":["Metallothionein \u2013 Immunohistochemical Cancer Biomarker: A Meta-Analysis"],"prefix":"10.1371","volume":"9","author":[{"given":"Jaromir","family":"Gumulec","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Raudenska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vojtech","family":"Adam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rene","family":"Kizek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Masarik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,1,8]]},"reference":[{"key":"ref1","first-page":"451","article-title":"Toxicological aspects of metallothionein","volume":"46","author":"M Nordberg","year":"2000","journal-title":"Cellular and Molecular Biology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/10409230091169168","article-title":"Induction, regulation, degradation, and biological significance of mammalian metallothioneins","volume":"35","author":"AT Miles","year":"2000","journal-title":"Critical Reviews in Biochemistry and Molecular Biology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/03602532.2012.725414","article-title":"Metallothioneins and zinc in cancer diagnosis and therapy","volume":"44","author":"S Krizkova","year":"2012","journal-title":"Drug Metabolism Reviews"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1046\/j.1523-1747.1998.00342.x","article-title":"Novel function of metallothionein in photoprotection: Metallothionein-null mouse exhibits reduced tolerance against ultraviolet B injury in the skin","volume":"111","author":"K Hanada","year":"1998","journal-title":"Journal of Investigative Dermatology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1046\/j.1365-2567.2000.00026.x","article-title":"Lack of metallothionein-I and -II exacerbates the immunosuppressive effect of ultraviolet B radiation and cis-urocanic acid in mice","volume":"100","author":"VE Reeve","year":"2000","journal-title":"Immunology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1002\/1097-0142(19931115)72:10<3029::AID-CNCR2820721027>3.0.CO;2-6","article-title":"Metallothionein in testicular germ-cell tumors and drug-resistance - clinical correlation","volume":"72","author":"JL Chin","year":"1993","journal-title":"Cancer"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1021\/cr020010d","article-title":"Biochemical modulation of cisplatin mechanisms of action: Enhancement of antitumor activity and circumvention of drug resistance","volume":"103","author":"MA Fuertes","year":"2003","journal-title":"Chemical Reviews"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.3748\/wjg.v11.i36.5696","article-title":"p53 negativity, CDC25B positivity, and metallothionein negativity are predictors of a response of esophageal squamous cell carcinoma to chemoradiotherapy","volume":"11","author":"F Sunada","year":"2005","journal-title":"World Journal of Gastroenterology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1126\/science.3175622","article-title":"Overexpression of metallothionein confers resistance to anticancer drugs","volume":"241","author":"SL Kelley","year":"1988","journal-title":"Science"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.freeradbiomed.2012.07.008","article-title":"Zinc supplementation prevents cardiomyocyte apoptosis and congenital heart defects in embryos of diabetic mice","volume":"53","author":"SD Kumar","year":"2012","journal-title":"Free Radical Biology and Medicine"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1039\/c2mt20081c","article-title":"Mammalian metallothioneins: properties and functions","volume":"4","author":"P Babula","year":"2012","journal-title":"Metallomics"},{"key":"ref12","first-page":"2423","article-title":"Metallothionein expression prevents apoptosis: A study with antisense phosphorothioate oligodeoxynucleotides in a human T cell line","volume":"18","author":"GT Tsangaris","year":"1998","journal-title":"Anticancer Research"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2174\/138920309788922243","article-title":"Metallothioneins and Cancer","volume":"10","author":"T Eckschlager","year":"2009","journal-title":"Current Protein and Peptide Science"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.mrfmmm.2003.07.013","article-title":"Metallothioneins in human tumors and potential roles in carcinogenesis","volume":"533","author":"MG Cherian","year":"2003","journal-title":"Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0197-0186(95)00116-6","article-title":"The antioxidant properties of zinc and metallothionein","volume":"29","author":"M Ebadi","year":"1996","journal-title":"Neurochemistry International"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1177\/153537020623100903","article-title":"Metallothionein redox cycle and function","volume":"231","author":"YJ Kang","year":"2006","journal-title":"Experimental Biology and Medicine"},{"key":"ref17","first-page":"325","article-title":"Oxygen free-radicals and metallothionein Free Radical Biology and Medicine","volume":"14","author":"M Sato","year":"1993"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0300-483X(95)03118-Y","article-title":"Effect of several metallothionein inducers on oxidative stress defense mechanisms in rats","volume":"104","author":"MB Iszard","year":"1995","journal-title":"Toxicology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0006-8993(98)00947-0","article-title":"Induction of astrocyte metallothioneins (MTs) by zinc confers resistance against the acute cytotoxic effects of methylmercury on cell swelling, Na+ uptake, and K+ release","volume":"813","author":"M Aschner","year":"1998","journal-title":"Brain Research"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00775-011-0823-6","article-title":"Mammalian metallothionein in toxicology, cancer, and cancer chemotherapy","volume":"16","author":"M Namdarghanbari","year":"2011","journal-title":"Journal of Biological Inorganic Chemistry"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0009-2797(94)03585-V","article-title":"Metallothionein protects DNA from copper-induced but not iron-induced cleavage in-vitro","volume":"96","author":"L Cai","year":"1995","journal-title":"Chemico-Biological Interactions"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2131\/jts.33.651","article-title":"Role of metallothionein as a protective factor against radiation carcinogenesis","volume":"33","author":"K Shibuya","year":"2008","journal-title":"Journal of Toxicological Sciences"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.1073\/pnas.92.10.4452","article-title":"Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric-oxide","volume":"92","author":"MA Schwarz","year":"1995","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1124\/mol.52.2.195","article-title":"Enhanced apoptosis in metallothionein null cells","volume":"52","author":"Y Kondo","year":"1997","journal-title":"Molecular Pharmacology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1872-034X.2007.00113.x","article-title":"Downregulated expression of metallothionein and its clinicopathological significance in hepatocellular carcinoma","volume":"37","author":"X Tao","year":"2007","journal-title":"Hepatology Research"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.proghi.2008.10.001","article-title":"The role of metallothionein in oncogenesis and cancer prognosis","volume":"44","author":"MO Pedersen","year":"2009","journal-title":"Progress in Histochemistry and Cytochemistry"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2559.2004.01922.x","article-title":"Metallothionein expression in human neoplasia","volume":"45","author":"SE Theocharis","year":"2004","journal-title":"Histopathology"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Takahashi S (2012) Molecular functions of metallothionein and its role in hematological malignancies. Journal of Hematology &amp; Oncology 5.","DOI":"10.1186\/1756-8722-5-41"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4149\/neo_2012_025","article-title":"Evaluation of alpha-methylacyl-CoA racemase, metallothionein and prostate specific antigen as prostate cancer prognostic markers","volume":"59","author":"J Gumulec","year":"2012","journal-title":"Neoplasma"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/BF02893459","article-title":"Clinicopathological significance of metallothioneins in breast cancer","volume":"10","author":"RX Jin","year":"2004","journal-title":"Pathology & Oncology Research"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1267\/ahc.34.171","article-title":"Analysis of metallothionein expression in human cancers","volume":"34","author":"BH Bay","year":"2001","journal-title":"Acta Histochemica et Cytochemica"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"JPT Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"R DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jrsm.12","article-title":"A basic introduction to fixed-effect and random-effects models for meta-analysis","volume":"1","author":"M Borenstein","year":"2010","journal-title":"Research Synthesis Methods"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/sj.bjc.6603028","article-title":"Metallothionein - overexpression as a highly significant prognostic factor in melanoma: a prospective study on 1270 patients","volume":"94","author":"G Weinlich","year":"2006","journal-title":"British Journal of Cancer"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF02893500","article-title":"Expression of P-glycoprotein and metallothionein in gastrointestinal stromal tumor and leiomyosarcomas. Clinical implications","volume":"13","author":"S Perez-Gutierrez","year":"2007","journal-title":"Pathology & Oncology Research"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1289\/ehp.00108413","article-title":"Metallothionein isoform 3 as a potential biomarker for human bladder cancer","volume":"108","author":"MA Sens","year":"2000","journal-title":"Environmental Health Perspectives"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.humpath.2011.04.015","article-title":"Metallothionein expression in colorectal cancer: relevance of different isoforms for tumor progression and patient survival","volume":"43","author":"JM Arriaga","year":"2012","journal-title":"Human Pathology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/jcp.52.12.876","article-title":"Prognostic evaluation of metallothionein expression in human colorectal neoplasms","volume":"52","author":"EE Ioachim","year":"1999","journal-title":"Journal of Clinical Pathology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0960-9776(02)00290-4","article-title":"Clinicopathological study of the expression of hsp27, pS2, cathepsin D and metallothionein in primary invasive breast cancer","volume":"12","author":"E Ioachim","year":"2003","journal-title":"Breast"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.oraloncology.2007.01.019","article-title":"The upregulation of metallothionein-1 expression in areca quid chewing-associated oral squamous cell carcinomas","volume":"44","author":"SS Lee","year":"2008","journal-title":"Oral Oncology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-2559.2011.03947.x","article-title":"Metallothionein expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patient survival","volume":"59","author":"S Theocharis","year":"2011","journal-title":"Histopathology"},{"key":"ref43","first-page":"1035","article-title":"Immunohistochemical detection of metallothionein in carcinomatous and normal human gastric mucosa","volume":"15","author":"G Tuccari","year":"2000","journal-title":"Histology and Histopathology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.urology.2005.09.033","article-title":"Metallothionein expression as prognostic factor for transitional cell carcinoma of bladder","volume":"67","author":"Y Yamasaki","year":"2006","journal-title":"Urology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/sj.bjc.6603254","article-title":"Multivariate analysis of oestrogen receptor alpha, pS2, metallothionein and CD24 expression in invasive breast cancers","volume":"95","author":"P Surowiak","year":"2006","journal-title":"British Journal of Cancer"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF01614773","article-title":"Localization of metallothionein in breast carcinomas - an immunohistochemical study","volume":"423","author":"M Fresno","year":"1993","journal-title":"Virchows Archiv A, Pathological Anatomy and Histopathology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000227546","article-title":"Immunohistochemical expression of metallothionein in invasive breast cancer in relation to proliferative activity, histology and prognosis","volume":"53","author":"T Oyama","year":"1996","journal-title":"Oncology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/bjc.1995.443","article-title":"Metallothionein expression in human breast-cancer","volume":"72","author":"H Goulding","year":"1995","journal-title":"British Journal of Cancer"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/carcin\/23.1.81","article-title":"Metallothionein 2A expression is associated with cell proliferation in breast cancer","volume":"23","author":"RX Jin","year":"2002","journal-title":"Carcinogenesis"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000055368","article-title":"Expression of metallothionein in colorectal cancers and synchronous liver metastases","volume":"61","author":"Y Hishikawa","year":"2001","journal-title":"Oncology"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00005537-200303000-00001","article-title":"Potential biomarkers for head and neck squamous cell carcinoma","volume":"113","author":"JJ Brown","year":"2003","journal-title":"Laryngoscope"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/S0959-8049(97)00216-5","article-title":"Metallothionein and Fas (CD95) are expressed in squamous cell carcinoma of the tongue","volume":"33","author":"K Sundelin","year":"1997","journal-title":"European Journal of Cancer"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Dutsch-Wicherek M, Lazar A, Tomaszewska R, Kazmierczak W, Wicherek L (2013) Analysis of metallothionein and vimentin immunoreactivity in pharyngeal squamous cell carcinoma and its microenvironment. Cell &amp; Tissue Research.","DOI":"10.1007\/s00441-013-1566-1"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0344-0338(99)80102-2","article-title":"Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: Correlation with p53 and proliferative cell nuclear antigen","volume":"195","author":"E Ioachim","year":"1999","journal-title":"Pathology Research and Practice"},{"key":"ref55","first-page":"335","article-title":"Prognostic significance of metallothionein, p53 protein and Ki-67 antigen expression in laryngeal cancer","volume":"27","author":"W Pastuszewski","year":"2007","journal-title":"Anticancer Research"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/S1452-3981(23)13868-5","article-title":"Study of Metallothionein Role in Spinocellular Carcinoma Tissues of Head and Neck Tumours using Brdicka Reaction","volume":"7","author":"J Sochor","year":"2012","journal-title":"International Journal of Electrochemical Science"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1525-1438.2002.01081.x","article-title":"Immunohistochemical localization of metallothionein in benign and malignant epithelial ovarian tumors","volume":"12","author":"WG McCluggage","year":"2002","journal-title":"International Journal of Gynecological Cancer"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1746-1596-7-124","article-title":"Immunohistochemistry with apoptotic-antiapoptotic proteins (p53, p21, bax, bcl-2), c-kit, telomerase, and metallothionein as a diagnostic aid in benign, borderline, and malignant serous and mucinous ovarian tumors","volume":"7","author":"H Ozer","year":"2012","journal-title":"Diagnostic Pathology"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<60::AID-PATH387>3.0.CO;2-J","article-title":"Metallothionein expression and nuclear size-in benign, borderline, and malignant serous ovarian tumours","volume":"189","author":"Y Tan","year":"1999","journal-title":"Journal of Pathology"},{"key":"ref60","first-page":"341","article-title":"Clinicopathological study of metallothionein immunohistochemical expression, in benign, borderline and malignant ovarian epithelial tumors","volume":"21","author":"N Zagorianakou","year":"2006","journal-title":"Histology and Histopathology"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/bjc.1991.160","article-title":"Metallothionein levels in ovarian-tumors before and after chemotherapy","volume":"63","author":"D Murphy","year":"1991","journal-title":"British Journal of Cancer"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00004347-199601000-00009","article-title":"Markers of chemoresistance in ovarian carcinomas: An immunohistochemical study of 86 cases","volume":"15","author":"I Germain","year":"1996","journal-title":"International Journal of Gynecological Pathology"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/BF02921379","article-title":"Metallothionein expression in normal, hyperplastic, and neoplastic thyroid follicular and parafollicular C-cells using monoclonal antimetallothionein antibody-E9","volume":"5","author":"KW Schmid","year":"1994","journal-title":"Endocrine Pathology"},{"key":"ref64","first-page":"4945","article-title":"Comparison of Metallothionein (MT) and Ki-67 Antigen Expression in Benign and Malignant Thyroid Tumours","volume":"30","author":"A Krolicka","year":"2010","journal-title":"Anticancer Research"},{"key":"ref65","first-page":"177","article-title":"Immunohistochemical localization of metallothionein in human thyroid-tumors","volume":"129","author":"N Nartey","year":"1987","journal-title":"American Journal of Pathology"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/labinvest.2008.17","article-title":"Metallothionein 1G acts as an oncosupressor in papillary thyroid carcinoma","volume":"88","author":"C Ferrario","year":"2008","journal-title":"Laboratory Investigation"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"Wei H, Desouki MM, Lin S, Xiao D, Franklin RB, et al. (2008) Differential expression of metallothioneins (MTs) 1, 2, and 3 in response to zinc treatment in human prostate normal and malignant cells and tissues. Molecular Cancer 7.","DOI":"10.1186\/1476-4598-7-7"},{"key":"ref68","first-page":"1145","article-title":"Metallothionein is up-regulated under hypoxia and promotes the survival of human prostate cancer cells","volume":"18","author":"M Yamasaki","year":"2007","journal-title":"Oncology Reports"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1476-4598-4-32","article-title":"hZIP 1 zinc uptake transporter down regulation and zinc depletion in prostate cancer","volume":"4","author":"R Franklin","year":"2005","journal-title":"Molecular Cancer"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1620\/tjem.166.251","article-title":"Metallothionein of prostatic tissues and fluids in rats and humans","volume":"166","author":"T Suzuki","year":"1992","journal-title":"Tohoku Journal of Experimental Medicine"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.2174\/092986711797636126","article-title":"Insight to Physiology and Pathology of Zinc(II) Ions and Their Actions in Breast and Prostate Carcinoma","volume":"18","author":"J Gumulec","year":"2011","journal-title":"Current Medicinal Chemistry"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1586\/era.11.190","article-title":"Cytotoxic\/tumor suppressor role of zinc for the treatment of cancer: an enigma and an opportunity","volume":"12","author":"LC Costello","year":"2012","journal-title":"Expert Review of Anticancer Therapy"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0168-8278(00)80277-9","article-title":"Relationship between copper, zinc and metallothionein in hepatocellular carcinoma and its surrounding liver parenchyma","volume":"33","author":"M Ebara","year":"2000","journal-title":"Journal of Hepatology"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3748\/wjg.v8.i4.650","article-title":"Metallothionein expression in hepatocellular carcinoma","volume":"8","author":"GW Huang","year":"2002","journal-title":"World Journal of Gastroenterology"},{"key":"ref75","first-page":"55","article-title":"The relationship between metallothionein-1F (MT1F) gene and hepatocellular carcinoma","volume":"76","author":"DD Lu","year":"2003","journal-title":"Yale Journal of Biology and Medicine"},{"key":"ref76","first-page":"477","article-title":"Detection of metallothionein 1G as a methylated tumor suppressor gene in human hepatocellular carcinoma using a novel method of double combination array analysis","volume":"35","author":"M Kanda","year":"2009","journal-title":"International Journal of Oncology"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/modpathol.3800674","article-title":"Positional expression profiling indicates candidate genes in deletion hotspots of hepatocellular carcinoma","volume":"19","author":"KYY Chan","year":"2006","journal-title":"Modern Pathology"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1248\/bpb.25.426","article-title":"A new diagnostic method for chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma based on serum metallothionein, copper, and zinc levels","volume":"25","author":"A Nakayama","year":"2002","journal-title":"Biological & Pharmaceutical Bulletin"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1248\/bpb.28.1137","article-title":"Evaluation of distribution patterns for copper and zinc in metallothionein and superoxide dismutase in chronic liver diseases and hepatocellular carcinoma using high-performance liquid chromatography (HPLC)","volume":"28","author":"S Kubo","year":"2005","journal-title":"Biological & Pharmaceutical Bulletin"},{"key":"ref80","first-page":"1995","article-title":"Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer","volume":"60","author":"MPA Ebert","year":"2000","journal-title":"Cancer Research"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/jso.20402","article-title":"p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate","volume":"93","author":"G Galizia","year":"2006","journal-title":"Journal of Surgical Oncology"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH712>3.0.CO;2-Z","article-title":"Metallothionein in human gastrointestinal cancer","volume":"192","author":"AML Janssen","year":"2000","journal-title":"Journal of Pathology"},{"key":"ref83","first-page":"636","article-title":"Histopathological study of metallothionein in bladder cancer and renal cell carcinoma","volume":"83","author":"T Saika","year":"1992","journal-title":"Nihon Hinyokika Gakkai Zasshi"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/toxsci\/kfj174","article-title":"Metallothionein-1 and-2 expression in cadmium- or arsenic-derived human malignant urothelial cells and tumor heterotransplants and as a prognostic indicator in human bladder cancer","volume":"91","author":"XD Zhou","year":"2006","journal-title":"Toxicological Sciences"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/oxfordjournals.jbchem.a002852","article-title":"Decreases of metallothionein and aminopeptidase N in renal cancer tissues","volume":"129","author":"K Ishii","year":"2001","journal-title":"Journal of Biochemistry"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0304-3835(00)00534-6","article-title":"In vivo gene expression profile analysis of metallothionein in renal cell carcinoma","volume":"160","author":"A Nguyen","year":"2000","journal-title":"Cancer Letters"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0378-4274(97)00049-0","article-title":"Expression of MT-3 mRNA in human kidney, proximal tubule cell cultures, and renal cell carcinoma","volume":"92","author":"JG Hoey","year":"1997","journal-title":"Toxicology Letters"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1159\/000045425","article-title":"Metallothioneins in human kidneys and associated tumors","volume":"83","author":"G Hellemans","year":"1999","journal-title":"Nephron"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000372-200102000-00005","article-title":"Immunohistochemical analysis of metallothionein expression in malignant melanoma in Japanese patients","volume":"23","author":"K Sugita","year":"2001","journal-title":"American Journal of Dermatopathology"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2559.1993.tb01198.x","article-title":"Immunohistochemically demonstrated metallothionein expression in malignant-melanoma","volume":"23","author":"B Zelger","year":"1993","journal-title":"Histopathology"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1046\/j.1365-2559.1998.00474.x","article-title":"Metallothionein expression in carcinoma of the gallbladder","volume":"33","author":"VK Shukla","year":"1998","journal-title":"Histopathology"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1007\/s00268-002-6266-z","article-title":"Metallothionein: Early marker in the carcinogenesis of ulcerative colitis-associated colorectal carcinoma","volume":"26","author":"M Bruewer","year":"2002","journal-title":"World Journal of Surgery"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00004347-199801000-00006","article-title":"Immunohistochemical detection of metallothionein and MIB1 in uterine cervical squamous lesions","volume":"17","author":"WG McCluggage","year":"1998","journal-title":"International Journal of Gynecological Pathology"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/PAI.0b013e31806d9b88","article-title":"Mean nuclear area and metallothionein expression in ductal breast tumors: Correlation with estrogen receptor status","volume":"16","author":"SL El Sharkarvy","year":"2008","journal-title":"Applied Immunohistochemistry & Molecular Morphology"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1023\/A:1006491405010","article-title":"Drug resistance-associated factors in primary and secondary glioblastomas and their precursor tumors","volume":"50","author":"DS Tews","year":"2000","journal-title":"Journal of Neuro-Oncology"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF00665963","article-title":"Immunohistochemical demonstration of metallothionein in normal human breast-tissue and benign and malignant breast-lesions","volume":"30","author":"B Bier","year":"1994","journal-title":"Breast Cancer Research and Treatment"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3748\/wjg.v13.i7.993","article-title":"Metallothionein: An overview","volume":"13","author":"N Thirumoorthy","year":"2007","journal-title":"World Journal of Gastroenterology"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s004320050130","article-title":"Do metallothioneins affect the response to treatment in testis cancers","volume":"124","author":"H Eid","year":"1998","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/(SICI)1097-0215(20000315)85:6<777::AID-IJC6>3.0.CO;2-D","article-title":"Role of metallothionein in cisplatin sensitivity of germ-cell tumours","volume":"85","author":"C Meijer","year":"2000","journal-title":"International Journal of Cancer"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/ijc.11006","article-title":"Hypermethylation, but not LOH, is associated with the low expression of MT1G and CRABP1 in papillary thyroid carcinoma","volume":"104","author":"Y Huang","year":"2003","journal-title":"International Journal of Cancer"},{"key":"ref101","first-page":"43","article-title":"Role of metallothionein expression in non-small cell lung carcinomas","volume":"49","author":"P Dziegiel","year":"2004","journal-title":"Roczniki Akademii Medycznej w Bialymstoku"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1007\/s00535-004-1471-1","article-title":"Immunohistochemical metallothionein expression in hepatocellular carcinoma: relation to tumor progression and chemoresistance to platinum agents","volume":"39","author":"T Endo","year":"2004","journal-title":"Journal of Gastroenterology"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ymeth.2010.08.004","article-title":"Differential zinc accumulation and expression of human zinc transporter 1 (hZIP1) in prostate glands","volume":"52","author":"LA Johnson","year":"2010","journal-title":"Methods"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/pros.20766","article-title":"Clinical assessment of the cancer diagnostic value of prostatic Zinc: A comprehensive needle-biopsy study","volume":"68","author":"M Cortesi","year":"2008","journal-title":"Prostate"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/cncr.10780","article-title":"Role of metallothioneins in irradiated human rectal carcinoma","volume":"95","author":"H Bouzourene","year":"2002","journal-title":"Cancer"},{"key":"ref106","first-page":"1118","article-title":"Expression of metallothionein and FasL in colorectal cancer and its clinical significance","volume":"43","author":"SY Li","year":"2005","journal-title":"Zhonghua Wai Ke Za Zhi (Chinese Journal of Surgery)"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00345-006-0141-8","article-title":"Metallothionein in bladder cancer: correlation of overexpression with poor outcome after chemotherapy","volume":"25","author":"C Wulfing","year":"2007","journal-title":"World Journal of Urology"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH616>3.0.CO;2-Q","article-title":"Immunohistochemical localization of metallothionein in endometrial lesions","volume":"191","author":"EE Ioachim","year":"2000","journal-title":"Journal of Pathology"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1365-2559.1999.00579.x","article-title":"High metallothionein expression is associated with features predictive of aggressive behaviour in endometrial carcinoma","volume":"34","author":"WG McCluggage","year":"1999","journal-title":"Histopathology"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0090-4295(98)00323-9","article-title":"Metallothionein expression in renal cancer","volume":"52","author":"JI Izawa","year":"1998","journal-title":"Urology"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1464-410x.1998.00506.x","article-title":"Incidence of apoptosis and metallothionein expression in renal cell carcinoma","volume":"81","author":"XH Zhang","year":"1998","journal-title":"British Journal of Urology"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1177\/153537020623100910","article-title":"Metallothionein as a prognostic biomarker in breast cancer","volume":"231","author":"BH Bay","year":"2006","journal-title":"Experimental Biology and Medicine"},{"key":"ref113","first-page":"107","article-title":"Evaluation of apoptosis, proliferation intensity and metallothionein (MT) expression in comparison with selected clinicopathological variables in primary adenocarcinomas of the large intestine","volume":"63","author":"M Dumanska","year":"2004","journal-title":"Folia Morphologica (Poland)"},{"key":"ref114","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s004280050046","article-title":"Immunoreactive p53 and metallothionein expression in duct carcinoma in situ of the breast - No correlation","volume":"430","author":"AG DouglasJones","year":"1997","journal-title":"Virchows Archiv"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.toxlet.2004.05.007","article-title":"Cigarette smoking and metallothionein expression in invasive breast carcinomas","volume":"152","author":"L Gallicchio","year":"2004","journal-title":"Toxicology Letters"},{"key":"ref116","doi-asserted-by":"crossref","first-page":"242","DOI":"10.2478\/v10042-010-0011-5","article-title":"Correlation between metallothionein (MT) expression and selected prognostic factors in ductal breast cancers","volume":"48","author":"A Gomulkiewicz","year":"2010","journal-title":"Folia Histochemica et Cytobiologica"},{"key":"ref117","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1699-0463.1995.tb01107.x","article-title":"The prognostic-significance of immunohistochemically detectable metallothionein in primary breast carcinomas","volume":"103","author":"T Haerslev","year":"1995","journal-title":"APMIS"},{"key":"ref118","first-page":"95","article-title":"Expression of metallothionein in invasive ductal breast cancer in relation to prognosis","volume":"19","author":"R Zhang","year":"2000","journal-title":"Journal of Environmental Pathology Toxicology and Oncology"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1023\/A:1010658907462","article-title":"Metallothionein 1F mRNA expression correlates with histological grade in breast carcinoma","volume":"66","author":"RX Jin","year":"2001","journal-title":"Breast Cancer Research and Treatment"},{"key":"ref120","first-page":"257","article-title":"Metallothionein immunoreactivity in head and neck carcinomas; Special reference to clinical behaviors and chemotherapy responses","volume":"20","author":"Y Muramatsu","year":"2000","journal-title":"Anticancer Research"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/030089160709300213","article-title":"The expression of metallothioneins on imprint smears of prostate carcinoma: Correlation with clinicopathologic parameters and tumor proliferative capacity","volume":"93","author":"P Athanassiadou","year":"2007","journal-title":"Tumori"},{"key":"ref122","first-page":"371","article-title":"Metallothionein expression in prostatic carcinoma: correlation with Gleason grade, pathologic stage, DNA content and serum level of prostate-specific antigen","volume":"20","author":"M Moussa","year":"1997","journal-title":"Clinical and Investigative Medicine-Medecine Clinique Et Experimentale"},{"key":"ref123","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/jcp.2005.033746","article-title":"Metallothionein isoform II expression in hyperplastic, dysplastic and neoplastic prostatic lesions","volume":"59","author":"SL El Sharkawy","year":"2006","journal-title":"Journal of Clinical Pathology"},{"key":"ref124","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/1097-0215(20010320)95:2<121::AID-IJC1021>3.0.CO;2-N","article-title":"Metallothionein expression in ovarian cancer in relation to histopathological parameters and molecular markers of prognosis","volume":"95","author":"JG Hengstler","year":"2001","journal-title":"International Journal of Cancer"},{"key":"ref125","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s00428-005-1228-0","article-title":"Augmented expression of metallothionein and glutathione S-transferase pi as unfavourable prognostic factors in cisplatin-treated ovarian cancer patients","volume":"447","author":"P Surowiak","year":"2005","journal-title":"Virchows Archiv"},{"key":"ref126","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1365-2559.2002.01325.x","article-title":"Expression of metallothionein in lung carcinoma: correlation with histological type and","volume":"40","author":"S Theocharis","year":"2002","journal-title":"Histopathology"},{"key":"ref127","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/sj.bjc.6690753","article-title":"Metallothionein expression correlates with metastatic and proliferative potential in squamous cell carcinoma of the oesophagus","volume":"81","author":"Y Hishikawa","year":"1999","journal-title":"British Journal of Cancer"},{"key":"ref128","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1468-3083.2006.02051.x","article-title":"Comparison of metallothionein-overexpression with sentinel lymph node biopsy as prognostic factors in melanoma","volume":"21","author":"G Weinlich","year":"2007","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"ref129","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0344-0338(11)80746-6","article-title":"Immunohistochemical detection of metallothionein in primary breast carcinomas and their axillary lymph-node metastases","volume":"190","author":"T Haerslev","year":"1994","journal-title":"Pathology Research and Practice"},{"key":"ref130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF01607167","article-title":"Presence and possible significance of immunocytochemically demonstrable metallothionein over-expression in primary invasive ductal carcinoma of the breast","volume":"422","author":"KW Schmid","year":"1993","journal-title":"Virchows Archiv A, Pathological Anatomy and Histopathology"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.yexmp.2012.10.006","article-title":"Metallothionein 1F and 2A overexpression predicts poor outcome of non-small cell lung cancer patients","volume":"94","author":"B Werynska","year":"2013","journal-title":"Experimental and Molecular Pathology"},{"key":"ref132","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00428-001-0588-3","article-title":"Prognostic impact of metallothionein on oral squamous cell carcinoma","volume":"441","author":"SV Cardoso","year":"2002","journal-title":"Virchows Archiv"},{"key":"ref133","first-page":"827","article-title":"Expression of ERCC1, Bcl-2, MT and their Clinical Significance in Advanced Non-small-cell Lung Cancer Treated With Cisplatin-based Chemotherapy","volume":"28","author":"HQ Ma","year":"2009","journal-title":"Latin American Journal of Pharmacy"},{"key":"ref134","first-page":"401","article-title":"Prognostic significance of metallothionein expression in correlation with Ki-67 expression in adenocarcinomas of large intestine","volume":"18","author":"P Dziegiel","year":"2003","journal-title":"Histology and Histopathology"},{"key":"ref135","doi-asserted-by":"crossref","unstructured":"Mitropoulos D, Kyroudi-Voulgari A, Theocharis S, Serafetinides E, Moraitis E, et al. (2005) Prognostic significance of metallothionein expression in renal cell carcinoma. World Journal of Surgical Oncology 3.","DOI":"10.1186\/1477-7819-3-5"},{"key":"ref136","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0003-4975(01)02838-7","article-title":"Tumor marker expression is predictive of survival in patients with esophageal cancer","volume":"72","author":"TA Aloia","year":"2001","journal-title":"Annals of Thoracic Surgery"},{"key":"ref137","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/1097-0142(20010815)92:4<836::AID-CNCR1390>3.0.CO;2-K","article-title":"Metallothionein expression in patients with small cell carcinoma of the lung - Correlation with other molecular markers and clinical outcome","volume":"92","author":"MG Joseph","year":"2001","journal-title":"Cancer"},{"key":"ref138","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.chroma.2011.10.015","article-title":"Analysis of metallothionein by capillary electrophoresis","volume":"1226","author":"M Ryvolova","year":"2012","journal-title":"Journal of Chromatography A"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0085346","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T18:44:58Z","timestamp":1716403498000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0085346"}},"subtitle":[],"editor":[{"given":"Renato","family":"Franco","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,8]]},"references-count":138,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0085346","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,8]]}}}